New Technologies in pipe line

• Rec and PEGylated Staphylokinase (IPR secured)
• New Immuno-inhibitors and bioactives (leads)
• Biosensors for pesticides and Glyc-Hb
• New TB Vaccine (IPR secured)
• Clot-specific, protein-engineered streptokinase (clinical trials in progress).
• "Healing" clot buster/s with clot-specific and anti-thrombin properties (licensed to US company in Nov. 2010).